Venrock Healthcare Capital Partners III, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Venrock Healthcare Capital Partners III, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Venrock Healthcare Capital Partners III, L.P.. Venrock Healthcare Capital Partners III, L.P. is a 10% Owner in Altimmune, Inc. ($ALT) and a 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a 10% Owner in Unum Therapeutics Inc. ($UMRX).
Address: C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO 94304 CA
Companies in which Venrock Healthcare Capital Partners III, L.P. is an Insider
Altimmune, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Venrock Healthcare Capital Partners III, L.P.: 10% Owner
Holdings: 3,500,000 shares
Current Value: $4,795,000
Latest Transaction: Mar 01 2021
$ALT Market Capitalization: $76.74M
$ALT Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cogent Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Venrock Healthcare Capital Partners III, L.P.: 10% Owner
Holdings: 4,004,273 shares
Latest Transaction: Aug 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONSTELLATION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Venrock Healthcare Capital Partners III, L.P.: 10% Owner
Holdings: 4,016,873 shares
Latest Transaction: Dec 16 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Venrock Healthcare Capital Partners III, L.P.
Sentiment: All, ALT, COGT, CNST
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | ALT | Altimmune, Inc. | Venrock Healthcare Capital Par ... | 10% Owner | Option Exercise | J | 0.00 | 1,000,000 | 100 | 1,000,000 | |
| Mar 01 2021 | ALT | Altimmune, Inc. | Venrock Healthcare Capital Par ... | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,500,000 | 4.5 M to 3.5 M (-22.22 %) |
| Aug 18 2020 | UMRX | Unum Therapeutics ... | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 2.62 | 101,000 | 264,620 | 4,355,273 | 4.3 M to 4.4 M (+2.37 %) |
| Aug 18 2020 | UMRX | Unum Therapeutics ... | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 2.57 | 250,000 | 642,500 | 4,254,273 | 4 M to 4.3 M (+6.24 %) |
| Aug 18 2020 | UMRX | Unum Therapeutics ... | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 2.30 | 100,000 | 230,000 | 4,004,273 | 3.9 M to 4 M (+2.56 %) |
| Jun 15 2020 | ALT | Altimmune, Inc. | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 7.54 | 1,500,000 | 11,310,000 | 4,500,000 | 3 M to 4.5 M (+50.00 %) |
| May 28 2020 | ALT | Altimmune, Inc. | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 8.87 | 173,711 | 1,540,817 | 3,000,000 | 2.8 M to 3 M (+6.15 %) |
View all Venrock Healthcare Capital Partners III, L.P. insider transactions.